About SCYNEXIS INC
Scynexis is a biopharmaceutical company focused on advancing innovative solutions for severe rare diseases, particularly targeting Autosomal Dominant Polycystic Kidney Disease (ADPKD) and life-threatening fungal infections through clinical-stage assets.
Development of AMPK activators (e.g., SCY-770)Research and development of antifungal triterpenoids (e.g., SCY-247)Targeting underlying biology of severe rare diseasesDrug development expertise in anti-infectives and metabolic disorders
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to SCYNEXIS INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.